<DOC>
	<DOCNO>NCT01207596</DOCNO>
	<brief_summary>The purpose study find Exalgo ( r ) beneficial patient neuropathic pain .</brief_summary>
	<brief_title>Evaluating Efficacy Safety Extended Release Hydromorphone ( Exalgo ) Patients With Neuropathic Pain</brief_title>
	<detailed_description>Neuropathic pain state usually refractory analgesic regimen require polypharmacy symptomatic relief . Current treatment option neuropathic pain include oral topical medication . Most commonly prescribed oral treatment include antidepressant ( eg , amitriptyline , desipramine , duloxetine ) , antiepileptic ( eg , gabapentin , pregabalin ) , opiates tramadol morphine . Current topical treatment include lidocaine patch capsaicin patch . Many patient inadequate pain relief spite treatment option . Currently , treatment available treatment neuropathy treat underlying cause address symptomatic relief pain . Current drug therapy neuropathic pain provide inadequate pain relief undesirable side effect include sedation cognitive dysfunction . It uncommon use combination agent treatment neuropathic pain minimize side effect . Although treat mild moderate pain may relatively easy , challenge severe neuropathic pain . Although use opiate neuropathic pain well accept , remain controversial potential abuse diversion .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>1. individual chronic pain 6 month duration 2. pain determine secondary document neuropathy 3. patient tolerant opiate ( 60 mg morphine equivalent least one week ) 4. male female patient age 1875 yr sign write informed consent form privacy statement 5. female patient childbearing potential must use acceptable form birth control 1. pregnant lactate woman 2. allergy morphine derivative 3. history alcohol substance abuse last 3 yrs 4. participation clinical trial last 30 day 5. uncontrolled pain 6. patient deem medically unstable principal investigator 7. history severe lung disease asthma deem medically significant principal investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Pain</keyword>
	<keyword>Neuropathy</keyword>
	<keyword>Neuropathic Pain</keyword>
	<keyword>Hydromorphone</keyword>
</DOC>